Exponent Inc. Appoints New Director, Sees Departure
Ticker: EXPO · Form: 8-K · Filed: Mar 1, 2024 · CIK: 851520
| Field | Detail |
|---|---|
| Company | Exponent INC (EXPO) |
| Form Type | 8-K |
| Filed Date | Mar 1, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, director-appointment, director-departure
TL;DR
Exponent Inc. board shakeup: Dr. Wood out, Dr. Webb in until 2026.
AI Summary
Exponent Inc. announced on February 26, 2024, the departure of director Dr. Steven D. Wood. Concurrently, the company elected Dr. Michael L. T. Webb as a new Class III director, effective immediately, to serve until the 2026 annual meeting of stockholders. Dr. Webb will also join the Audit Committee and the Compensation Committee.
Why It Matters
The appointment of a new director and the departure of another can signal shifts in board strategy or governance, potentially impacting future company decisions and performance.
Risk Assessment
Risk Level: low — The filing reports routine board changes and does not indicate any significant financial distress or operational issues.
Key Numbers
- 2026 — Director Term End (Dr. Webb's term as a Class III director will conclude at the 2026 annual meeting of stockholders.)
Key Players & Entities
- Exponent Inc. (company) — The company filing the report.
- Dr. Steven D. Wood (person) — Director who departed the board.
- Dr. Michael L. T. Webb (person) — Newly elected director.
- Class III director (context) — The class of directorship Dr. Webb was elected to.
- Audit Committee (context) — Committee Dr. Webb will join.
- Compensation Committee (context) — Committee Dr. Webb will join.
FAQ
What was the effective date of Dr. Steven D. Wood's departure?
The filing indicates Dr. Steven D. Wood's departure was effective February 26, 2024.
What is the term length for the newly elected director, Dr. Michael L. T. Webb?
Dr. Michael L. T. Webb was elected as a Class III director and will serve until the 2026 annual meeting of stockholders.
Which committees will Dr. Michael L. T. Webb join?
Dr. Michael L. T. Webb will join the Audit Committee and the Compensation Committee.
What is Exponent Inc.'s principal executive office address?
Exponent Inc.'s principal executive office is located at 149 Commonwealth Drive, Menlo Park, California 94025.
What is the filing date of this 8-K report?
This 8-K report was filed on March 1, 2024.
Filing Stats: 448 words · 2 min read · ~1 pages · Grade level 11.8 · Accepted 2024-03-01 16:12:50
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share EXPO Nasdaq Global Select
Filing Documents
- expo-20240226.htm (8-K) — 34KB
- 0000950170-24-023858.txt ( ) — 141KB
- expo-20240226.xsd (EX-101.SCH) — 23KB
- expo-20240226_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EXPONENT, INC. Date: March 1, 2024 By: /s/ Richard L. Schlenker Richard L. Schlenker Executive Vice President, Chief Financial Officer and Corporate Secretary